FRAG-RIP 5 mg x 5 Vials – Denik Pharm

Description

Denik Pharm FRAG-RIP 5 mg is a premium research formulation containing Human Growth Hormone Fragment 176-191 (HGH Frag 176-191), a precisely engineered peptide representing the biologically active C-terminal segment of the native Human Growth Hormone molecule. Developed specifically for scientific investigation, this peptide enables researchers to examine metabolic regulation, lipid metabolism, and energy homeostasis without encompassing the full spectrum of physiological actions associated with intact Growth Hormone.

The selective nature of HGH Fragment 176-191 has made it an important molecule in metabolic research, allowing laboratories to isolate and study pathways related to adipocyte biology, nutrient utilization, and cellular energy expenditure. Its focused mechanism provides researchers with a valuable model for understanding how specific regions of the Growth Hormone molecule contribute to metabolic signaling at the molecular level.

Each package contains 5 lyophilized vials, with 5 mg of HGH Fragment 176-191 per vial, manufactured by Denik Pharm under stringent pharmaceutical-quality standards. Every batch is produced to ensure exceptional purity, molecular stability, and batch-to-batch consistency for advanced laboratory research.

Key Features

• Premium Human Growth Hormone Fragment 176-191 (HGH Frag) research peptide
• 5 mg of high-purity peptide per vial
• 5 lyophilized vials per pack
• Synthetic C-terminal fragment of Human Growth Hormone
• High-purity laboratory-grade formulation
• Extensively researched in metabolic physiology and endocrine biology
• Suitable for investigations involving lipid metabolism, adipocyte biology, energy homeostasis, and molecular signaling
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

HGH Fragment 176-191 is derived from the terminal amino acid sequence of Human Growth Hormone and is extensively investigated for its interaction with biological pathways involved in fat metabolism and metabolic regulation. Unlike full-length Growth Hormone, this peptide allows researchers to focus specifically on molecular mechanisms associated with lipid utilization and energy balance.

In laboratory settings, FRAG-RIP is commonly utilized to study adipocyte signaling, cellular energy metabolism, and the regulation of metabolic pathways associated with nutrient utilization. Researchers also investigate its influence on intracellular signaling networks involved in metabolic adaptation, making it an important research tool for advancing the understanding of endocrine metabolism and growth hormone-derived biological processes.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredient: Human Growth Hormone Fragment 176-191 – 5 mg

Packaging: 5 Lyophilized Vials